Cargando…
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373910/ https://www.ncbi.nlm.nih.gov/pubmed/25807248 http://dx.doi.org/10.1371/journal.ppat.1004767 |
_version_ | 1782363409928421376 |
---|---|
author | Derking, Ronald Ozorowski, Gabriel Sliepen, Kwinten Yasmeen, Anila Cupo, Albert Torres, Jonathan L. Julien, Jean-Philippe Lee, Jeong Hyun van Montfort, Thijs de Taeye, Steven W. Connors, Mark Burton, Dennis R. Wilson, Ian A. Klasse, Per-Johan Ward, Andrew B. Moore, John P. Sanders, Rogier W. |
author_facet | Derking, Ronald Ozorowski, Gabriel Sliepen, Kwinten Yasmeen, Anila Cupo, Albert Torres, Jonathan L. Julien, Jean-Philippe Lee, Jeong Hyun van Montfort, Thijs de Taeye, Steven W. Connors, Mark Burton, Dennis R. Wilson, Ian A. Klasse, Per-Johan Ward, Andrew B. Moore, John P. Sanders, Rogier W. |
author_sort | Derking, Ronald |
collection | PubMed |
description | The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation of many bNAbs against multiple different epitopes; 2) the generation of a soluble trimer mimic, BG505 SOSIP.664 gp140, that expresses most bNAb epitopes; 3) facile binding assays involving the oriented immobilization of tagged trimers. Using these tools, we generated an antigenic map of the trimer by antibody cross-competition. Our analysis delineates three well-defined epitope clusters (CD4 binding site, quaternary V1V2 and Asn332-centered oligomannose patch) and new epitopes at the gp120-gp41 interface. It also identifies the relationships among these clusters. In addition to epitope overlap, we defined three more ways in which antibodies can cross-compete: steric competition from binding to proximal but non-overlapping epitopes (e.g., PGT151 inhibition of 8ANC195 binding); allosteric inhibition (e.g., PGT145 inhibition of 1NC9, 8ANC195, PGT151 and CD4 binding); and competition by reorientation of glycans (e.g., PGT135 inhibition of CD4bs bNAbs, and CD4bs bNAb inhibition of 8ANC195). We further demonstrate that bNAb binding can be complex, often affecting several other areas of the trimer surface beyond the epitope. This extensive analysis of the antigenic structure and the epitope interrelationships of the Env trimer should aid in design of both bNAb-based therapies and vaccines intended to induce bNAbs. |
format | Online Article Text |
id | pubmed-4373910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43739102015-03-27 Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer Derking, Ronald Ozorowski, Gabriel Sliepen, Kwinten Yasmeen, Anila Cupo, Albert Torres, Jonathan L. Julien, Jean-Philippe Lee, Jeong Hyun van Montfort, Thijs de Taeye, Steven W. Connors, Mark Burton, Dennis R. Wilson, Ian A. Klasse, Per-Johan Ward, Andrew B. Moore, John P. Sanders, Rogier W. PLoS Pathog Research Article The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation of many bNAbs against multiple different epitopes; 2) the generation of a soluble trimer mimic, BG505 SOSIP.664 gp140, that expresses most bNAb epitopes; 3) facile binding assays involving the oriented immobilization of tagged trimers. Using these tools, we generated an antigenic map of the trimer by antibody cross-competition. Our analysis delineates three well-defined epitope clusters (CD4 binding site, quaternary V1V2 and Asn332-centered oligomannose patch) and new epitopes at the gp120-gp41 interface. It also identifies the relationships among these clusters. In addition to epitope overlap, we defined three more ways in which antibodies can cross-compete: steric competition from binding to proximal but non-overlapping epitopes (e.g., PGT151 inhibition of 8ANC195 binding); allosteric inhibition (e.g., PGT145 inhibition of 1NC9, 8ANC195, PGT151 and CD4 binding); and competition by reorientation of glycans (e.g., PGT135 inhibition of CD4bs bNAbs, and CD4bs bNAb inhibition of 8ANC195). We further demonstrate that bNAb binding can be complex, often affecting several other areas of the trimer surface beyond the epitope. This extensive analysis of the antigenic structure and the epitope interrelationships of the Env trimer should aid in design of both bNAb-based therapies and vaccines intended to induce bNAbs. Public Library of Science 2015-03-25 /pmc/articles/PMC4373910/ /pubmed/25807248 http://dx.doi.org/10.1371/journal.ppat.1004767 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Derking, Ronald Ozorowski, Gabriel Sliepen, Kwinten Yasmeen, Anila Cupo, Albert Torres, Jonathan L. Julien, Jean-Philippe Lee, Jeong Hyun van Montfort, Thijs de Taeye, Steven W. Connors, Mark Burton, Dennis R. Wilson, Ian A. Klasse, Per-Johan Ward, Andrew B. Moore, John P. Sanders, Rogier W. Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer |
title | Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer |
title_full | Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer |
title_fullStr | Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer |
title_full_unstemmed | Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer |
title_short | Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer |
title_sort | comprehensive antigenic map of a cleaved soluble hiv-1 envelope trimer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373910/ https://www.ncbi.nlm.nih.gov/pubmed/25807248 http://dx.doi.org/10.1371/journal.ppat.1004767 |
work_keys_str_mv | AT derkingronald comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT ozorowskigabriel comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT sliepenkwinten comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT yasmeenanila comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT cupoalbert comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT torresjonathanl comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT julienjeanphilippe comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT leejeonghyun comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT vanmontfortthijs comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT detaeyestevenw comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT connorsmark comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT burtondennisr comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT wilsoniana comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT klasseperjohan comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT wardandrewb comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT moorejohnp comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer AT sandersrogierw comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer |